IL6/IL10/TLR4 Govern Immunogenic Cell Death in Aortic Dissection
Cardiovascular Therapeutics · 2026-01 · 2026 (1)
DOI: 10.1155/cdr/4140685 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Therapeutics, online erschienen am 28.03.2026. Verfasst von Yukui Du und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Center for Cardiac and Panvascular Medicine, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, …. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Aortic Dissection, Interleukin-6, Interleukin-10. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Human Resources and Social Security of Xinjiang Uygur Autonomous Region, Xinjiang Uygur Autonomous Region Natural Science Fund, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Aortic dissection (AD), a life‐threatening cardiovascular emergency, poses a significant threat to global cardiovascular health. Emerging evidence implicates programmed cell death (PCD) as a critical driver of AD pathogenesis, yet the molecular mechanisms remain poorly defined. This study systematically investigates PCD‐related biomarkers in AD to identify novel therapeutic targets.
Methods
Multiomics analysis integrated transcriptome sequencing data from eight AD and five control aortic tissues. Differentially expressed genes (DEmRNAs, n = 3094) were intersected with 1574 programmed cell death–related genes (PCD‐RGs) to identify candidate biomarkers. Protein–protein interaction (PPI) networks, functional enrichment, immune infiltration profiling, and drug‐target prediction were employed to characterize key molecular drivers.
Results
Three PCD‐associated biomarkers were identified: IL6 (11.8‐fold upregulated), IL10 (26.1‐fold upregulated), and TLR4 (0.38‐fold downregulated). These biomarkers exhibited significant enrichment in immunoregulatory pathways including “MYC Targets V1” (FDR < 0.05), with IL10 showing strong immune microenvironment correlations (memory B cells: r = 0.62; endothelial cells: r = −0.58). Regulatory network analysis revealed 58 transcription factors (STAT1/SP1/IRF8) and six key miRNAs (e.g., miR‐204‐5p) orchestrating biomarker expression. Drug‐target mapping identified 91 repurposable agents, including etanercept‐szzs (dual IL6/IL10 inhibitor) and TLR4‐modulating compounds.
Conclusion
This study establishes IL6, IL10, and TLR4 as central regulators of PCD‐mediated AD pathogenesis, implicating immune–vascular crosstalk and immunogenic cell death as therapeutic entry points. The identified biomarker network and drug candidates provide a translational framework for developing precision therapies against AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiac Surgery, Center for Cardiac and Panvascular Medicine, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
- Department of Anesthesiology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
- Cardiovascular Medicine Department, Center for Cardiac and Panvascular Medicine, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
- Capital Center for Children's Health, Capital Medical University, Capital Institute of Pediatrics, Beijing, China, shouer.com.cn.
ORCID-Profile: Yukui Du, Dongqing Chang, Bofeng Yu, Li Zhang, Liang He, Fengxia Wang, Shaoyan Chang
Förderung
- Department of Human Resources and Social Security of Xinjiang Uygur Autonomous Region
- Xinjiang Uygur Autonomous Region Natural Science Fund
- National Natural Science Foundation of China
Zitieren
APA
Du, Y., Chang, D., Yu, B., Zhang, L., He, L., Wang, F., & Chang, S. (2026). IL6/IL10/TLR4 Govern Immunogenic Cell Death in Aortic Dissection. Cardiovascular Therapeutics, 2026(1). https://doi.org/10.1155/cdr/4140685
Vancouver
Du Y, Chang D, Yu B, Zhang L, He L, Wang F, et al. IL6/IL10/TLR4 Govern Immunogenic Cell Death in Aortic Dissection. Cardiovascular Therapeutics. 2026;2026(1). doi:10.1155/cdr/4140685
BibTeX
@article{Du2026,
author = {Du, Yukui and Chang, Dongqing and Yu, Bofeng and Zhang, Li and He, Liang and Wang, Fengxia and Chang, Shaoyan},
title = {IL6/IL10/TLR4 Govern Immunogenic Cell Death in Aortic Dissection},
journal = {Cardiovascular Therapeutics},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/cdr/4140685}
}
EUVIMED